Placebo surgery in trials of therapy for Parkinson's disease
Horisberger, J.D.
New England Journal of Medicine 342(5): 354-355
2000
ISSN/ISBN: 0028-4793 PMID: 10660399 Document Number: 516893
Document emailed within 1 workday
Related Documents
Slattery, J. 2000: Placebo surgery in trials of therapy for Parkinson's disease New England Journal of Medicine 342(5): 354; Author Reply 355Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13
Bretlau, P.; Thomsen, J.; Tos, M.; Johnsen, N.J. 1984: Placebo effect in surgery for Meniere's disease: a three-year follow-up study of patients in a double blind placebo controlled study on endolymphatic sac shunt surgery American Journal of Otology 5(6): 558-561
Hauser, R.A.; Zesiewicz, T.A. 2006: Clinical trials aimed at detecting neuroprotection in Parkinson's disease Neurology 66(10 Suppl 4): S58-S68
Counsell, C. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required Bmj 317(7172): 1586
Leenders, K.L. 1997: PET modifications after surgery for Parkinson's disease Advances in Neurology 74: 271-279
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Obeso, J.A.; Rodriguez-Oroz, M.C.; Rodriguez, M.; Macias, R.; Alvarez, L.; Guridi, J.; Vitek, J.; DeLong, M.R. 2000: Pathophysiologic basis of surgery for Parkinson's disease Neurology 55(12 Suppl 6: S7-12
Olanow, C.W.; Marsden, C.D.; Lang, A.E.; Goetz, C.G. 1994: The role of surgery in Parkinson's disease management Neurology 44(3 Suppl 1: S17-S20
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Gildenberg, P.L. 1984: The present role of stereotactic surgery in the management of Parkinson's disease Advances in Neurology 40: 447-452
Roth, J.; Růzicka, E.; Kanovský, P. 2000: Advance in therapy Parkinson's disease Vnitrni Lekarstvi 46(11): 811-816
Bhat, V.; Weiner, W.J. 2005: Parkinson's disease. Diagnosis and the initiation of therapy Minerva Medica 96(3): 145-154
Shamsudin, N.; Fleischer, A.B. 2010: Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journals Journal of Drugs in Dermatology: Jdd 9(10): 1221-1226
Möller, J.C.; Sautter, J.; Kupsch, A. 1996: Potential of neurotrophic factors in therapy of Parkinson's disease Journal of Neural Transmission. Supplementum 48: 103-112
Gehlen, W. 1980: Adverse effects of drug therapy in Parkinson disease Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110
1997: Parkinson disease--planning of long-term therapy Der Nervenarzt 68(12 Suppl Morbus Par): 1-8
Kellner, C.H.; Beale, M.D.; Pritchett, J.T.; Bernstein, H.J.; Burns, C.M. 1994: Electroconvulsive therapy and Parkinson's disease: the case for further study Psychopharmacology Bulletin 30(3): 495-500